NASDAQ: RGNXRegenxbio Inc Stock Ownership - Who owns Regenxbio?
Insider buying vs selling
Have Regenxbio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Steve Pakola | Chief Medical Officer | 2026-03-10 | 5,124 | $10.35 | $53.03kSell |
| Patrick J. Christmas | Chief Strategy Legal Officer | 2026-02-01 | 4,700 | $11.16 | $52.45kSell |
| Steve Pakola | Chief Medical Officer | 2026-02-01 | 5,267 | $11.16 | $58.78kSell |
| Kenneth T. Mills | Director | 2026-01-27 | 221,753 | $13.41 | $2.97MSell |
| Kenneth T. Mills | Director | 2026-01-27 | 225,000 | $13.09 | $2.95MBuy |
| Curran Simpson | Chief Executive Officer | 2026-01-02 | 18,559 | $14.40 | $267.25kSell |
| Patrick J. Christmas | Chief Strategy Legal Officer | 2026-01-02 | 9,793 | $14.40 | $141.02kSell |
| Craig Malzahn | Chief Technology Officer | 2026-01-02 | 1,238 | $14.40 | $17.83kSell |
| Steve Pakola | Chief Medical Officer | 2026-01-02 | 18,247 | $14.40 | $262.76kSell |
| Curran Simpson | Chief Executive Officer | 2025-10-09 | 20,811 | $12.62 | $262.63kSell |
RGNX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RGNX insiders and whales buy or sell their stock.
RGNX Shareholders
What type of owners hold Regenxbio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Allan M. Fox | 13.38% | 6,905,721 | $58.42M | Insider |
| Blackrock Inc | 11.15% | 5,756,811 | $48.70M | Institution |
| Redmile Group LLC | 8.46% | 4,368,804 | $36.96M | Institution |
| Jpmorgan Chase Co | 6.88% | 3,553,502 | $30.06M | Institution |
| Vanguard Group Inc | 6.54% | 3,374,140 | $28.55M | Institution |
| Fmr LLC | 4.66% | 2,406,547 | $20.36M | Insider |
| State Street Corp | 4.43% | 2,286,736 | $19.35M | Institution |
| Morgan Stanley | 3.90% | 2,014,788 | $17.05M | Institution |
| Goldman Sachs Group Inc | 3.46% | 1,785,437 | $15.10M | Institution |
| Goldman Sachs Group Inc 1 | 3.46% | 1,785,437 | $15.10M | Institution |
RGNX vs Biotech Stocks
Regenxbio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.